Treatment of Toxoplasmosis in Pregnancy: Concentrations of Spiramycin and Neospiramycin in Maternal Serum and Amniotic Fluid
✍ Scribed by R. Gratzl; G. Sodeck; P. Platzer; W. Jäger; J. Graf; A. Pollak; T. Thalhammer
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 59 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract **Objective:** To evaluate the effect of maternal oral hydration on amniotic fluid index (AFI) in women with pregnancy‐induced hypertension. **Methods:** Five women with pregnancy‐induced hypertension and five normotensive gravidae at 32–37 weeks gestation with normal AFI (8–18 cm) wer
Maternal serum inhibin-A concentration is a useful marker in prenatal screening for Down syndrome in the second trimester. We measured inhibin-A concentrations in 4304 pregnancies without Down syndrome between 14 and 22 weeks of pregnancy to determine the median values according to gestational age.